血管生成素-2介导血管性血友病因子与人95D肺癌细胞相互作用
首发时间:2025-04-10
摘要:目的:验证血管生成素-2(Angiopoietin-2,Ang-2)介导血管性血友病因子(Von Willebrand Factor,VWF)与人高转移肺癌细胞(95D)相互作用。方法:采用流式细胞术测定95D细胞表面Ang-2、Tie-2的表达情况,VWF及其各结构域与95D细胞的结合能力。并使用细胞粘附实验进一步测定VWF与95D细胞的结合。酶连免疫法(Enzyme-linked immunosorbent assay,ELISA)检测Ang-2与VWF A1结构域的相互作用。用Ang-2的抗体和Tie-2的抑制剂去阻断VWF及VWF A1结构域与95D细胞的结合。结果:95D细胞表面有Ang-2、Tie-2表达。VWF能与95D细胞直接相互作用,且作用位点主要在VWF A1结构域。酶联免疫结果显示,Ang-2以高亲和力与VWF A1结合。用Ang-2抗体和Tie-2的抑制剂阻断VWF和Ang-2结合位点后,VWF与95D细胞的结合明显减弱。结论:Ang-2介导了VWF和95D之间的相互作用,为肿瘤的治疗和药物研究提供了新的靶点。
关键词: 血管性血友病因子;血管生成素-2 肿瘤
For information in English, please click here
Angiopoietin-2-mediated Interactions between Von Willebrand Factor and 95D Cells
Abstract:Objective: To verify the mediation role of Angiopoietin-2 (Ang-2) in the interaction between von Willebrand Factor (VWF) and highly metastatic human lung cancer cells (95D). Methods: Flow cytometry was employed to assess the expression levels of Ang-2 and Tie-2 on the surface of 95D cells,as well as the binding capacity of VWF and its various domains with 95D cells. Cell adhesion assays were further conducted to measure the binding between VWF and 95D cells. Enzyme-linked immunosorbent assay (ELISA) was utilized to detect the interaction between Ang-2 and the VWF A1 domain. The binding sites between VWF, its A1 domain, and 95D cells were blocked using antibodies against Ang-2 and inhibitors of Tie-2. Results: Expression of Ang-2 and Tie-2 was detected on the surface of 95D cells. VWF could directly interact with 95D cells, primarily through the VWF A1 domain. ELISA results showed that Ang-2 binds to the VWF A1 domain with high affinity. Blocking the binding sites of VWF and Ang-2 with Ang-2 antibodies and Tie-2 inhibitors significantly weakened the binding between VWF and 95D cells. Conclusion: Ang-2 mediates the interaction between VWF and 95D cells, providing a new therapeutic target for cancer treatment and drug research.
基金:
引用

No.****
动态公开评议
共计0人参与
勘误表
血管生成素-2介导血管性血友病因子与人95D肺癌细胞相互作用
评论
全部评论